Dominique Figarella-Branger
Affiliations: | Aix Marseille 2 |
Area:
Glioblastomas, Treatment, Proscillaridin A, Tumor location, Braf, pediatric brain tumors, molecular profil, DNT, low grade glioma, pilocytic astrocytoma, ganglioglioma, Tenascin R, Pilocytic astrocytomas, Extracellular matrix, Angiogenesis, InvasivenessGoogle:
"Dominique Figarella-Branger"Mean distance: (not calculated yet)
Children
Sign in to add traineeLaurent Daniel | grad student | 2001 | Aix-Marseille 2 |
Corinne Bouvier | grad student | 2003 | Aix-Marseille 2 |
Carole Colin | grad student | 2006 | Aix Marseille 2 |
Carla Fernandez | grad student | 2006 | Aix Marseille 2 |
Béma Coulibaly | grad student | 2009 | Aix Marseille 2 |
Aurélie Tchoghandjian | grad student | 2009 | Aix Marseille 2 |
Ikbale El Ayachi | grad student | 2010 | Aix Marseille 2 |
Laëtitia Padovani | grad student | 2013 | Aix-Marseille University |
Sandy Mercurio | grad student | 2013 | Aix-Marseille University |
Emilie Denicolaï | grad student | 2015 | Aix-Marseille University |
Emeline Tabouret | grad student | 2015 | Aix-Marseille University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hein V, Baeza-Kallee N, Bertucci A, et al. (2024) GD3 ganglioside is a promising therapeutic target for glioma patients. Neuro-Oncology Advances. 6: vdae038 |
Harlay V, Appay R, Bequet C, et al. (2023) Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM). Neuro-Oncology Practice. 10: 536-543 |
Ariey-Bonnet J, Berges R, Montero MP, et al. (2023) Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. Ebiomedicine. 95: 104752 |
Baeza-Kallee N, Bergès R, Hein V, et al. (2023) Deciphering the Action of Neuraminidase in Glioblastoma Models. International Journal of Molecular Sciences. 24 |
Appay R, Sarri B, Heuke S, et al. (2023) Live Stimulated Raman Histology for the Near-Instant Assessment of Central Nervous System Samples. The Journal of Physical Chemistry. B |
Bikfalvi A, da Costa CA, Avril T, et al. (2023) Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023). Trends in Cancer |
Métais A, Tauziède-Espariat A, Garcia J, et al. (2023) Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion. Acta Neuropathologica Communications. 11: 14 |
Keck MK, Sill M, Wittmann A, et al. (2022) Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathologica |
Montégut C, Guillamo JS, Ducray F, et al. (2022) Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade -Mutant Gliomas: A French POLA Network Study. Cancers. 14 |
Picart T, Poncet D, Barritault M, et al. (2022) Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis. The American Journal of Surgical Pathology. 47: 131-144 |